Table of Contents

Open the drop down below and select title to jump to content

Get started today

Book a Consultation

Book a Procedure

Skin Tag Diabetes Connection

  • Diabetic patients are up to three times more likely to develop multiple skin tags compared to non-diabetic individuals, with a stronger correlation in Type 2 diabetes.
  • Insulin resistance is the primary mechanism linking skin tags to diabetes, as excess insulin activates growth factors in skin cells that promote skin tag formation.
  • Multiple skin tags (especially more than five) may serve as early warning signs of prediabetes, often appearing before laboratory abnormalities are detected.
  • Diabetic patients should be aware of other skin manifestations beyond skin tags, including acanthosis nigricans, diabetic dermopathy, and increased susceptibility to infections.
  • Treatment of skin tags in diabetic patients requires special consideration for wound healing and infection risk, with options including cryotherapy, electrosurgery, and laser therapy.
  • Preventing skin tags in diabetic patients primarily involves maintaining optimal glycemic control (HbA1c below 7%), weight management, and regular physical activity.
  • Diabetic patients should seek prompt dermatological care for multiple new skin tags, atypical features in existing tags, or post-removal complications.

Table of Contents

How Insulin Resistance Contributes to Skin Tag Formation

Insulin resistance stands as the central mechanism linking skin tags to diabetes and broader metabolic syndrome. In this condition, cells become less responsive to insulin’s effects, prompting the pancreas to produce increasingly higher amounts of insulin to maintain normal blood glucose levels. This hyperinsulinaemia creates a cascade of dermatological consequences that directly contribute to skin tag development.

At the cellular level, excess insulin activates insulin-like growth factor-1 (IGF-1) receptors in keratinocytes and fibroblasts within the epidermis. This activation stimulates cellular proliferation and inhibits apoptosis (programmed cell death), creating ideal conditions for skin tag formation. Additionally, insulin enhances the expression of epidermal growth factors and increases tissue sensitivity to growth hormones, further promoting the development of these benign skin growths.

The distribution pattern of skin tags often correlates with insulin receptor density in the skin. Areas with skin folds, such as the neck and axillae, not only experience increased friction but also demonstrate higher insulin receptor concentration, explaining the predilection for skin tag formation in these regions. Research from metabolic syndrome dermatology studies indicates that the number and size of skin tags often correlate with the severity of insulin resistance, making them potential visual markers for metabolic health.

For patients experiencing both skin tags and symptoms of insulin resistance, comprehensive management approaches that address both conditions simultaneously yield the most favourable outcomes. Managing skin tags and insulin resistance effectively requires collaboration between dermatologists and endocrinologists to address both the visible manifestations and underlying metabolic dysfunction.

Recognizing Diabetic Skin Changes Beyond Skin Tags

Diabetes affects the skin through multiple pathways, producing a constellation of dermatological manifestations that extend well beyond skin tags. Recognising these associated conditions enables more comprehensive patient care and may reveal important clues about glycaemic control. Among the most significant diabetic skin changes is acanthosis nigricans—characterised by velvety, hyperpigmented plaques typically found in body folds. Like skin tags, acanthosis nigricans strongly correlates with insulin resistance and often coexists with multiple acrochordons.

Diabetic dermopathy presents as light brown, scaly patches predominantly on the shins, affecting up to 55% of patients with long-standing diabetes. These lesions, sometimes called “shin spots,” result from microangiopathic changes and serve as markers of vascular compromise. Necrobiosis lipoidica diabeticorum, though less common, produces distinctive yellow-brown, atrophic plaques with telangiectasias and carries significant cosmetic and functional implications.

Fungal infections, particularly candidiasis, occur with increased frequency and severity in diabetic patients due to elevated glucose levels in tissues and impaired immune function. These infections commonly affect intertriginous areas, oral mucosa, and genital regions. Bacterial infections, including staphylococcal folliculitis and erysipelas, also demonstrate higher prevalence and more aggressive courses in diabetic populations.

Diabetic bullae (bullosis diabeticorum) represent a rare but pathognomonic finding—spontaneous, non-inflammatory blisters typically appearing on the extremities. Xerosis (dry skin) affects nearly all diabetic patients to some degree, predisposing them to fissures, infections, and pruritus. Recognising this spectrum of diabetic skin changes enables dermatologists to serve as crucial partners in diabetes management, often identifying subtle signs of metabolic derangement before they manifest systemically.

Are Skin Tags a Warning Sign for Prediabetes?

Emerging evidence suggests that skin tags may serve as early cutaneous markers for prediabetic states, potentially offering a visible window into metabolic health before laboratory abnormalities become apparent. Multiple cross-sectional studies have demonstrated significant associations between skin tag presence and impaired glucose tolerance, even in patients with normal fasting blood glucose levels. This relationship positions dermatological assessment as a potentially valuable screening tool in preventative medicine.

The predictive value of skin tags appears particularly strong when they present with certain characteristics: multiple in number (typically more than five), larger in size (>5mm), and distributed across several anatomical sites. Research indicates that individuals with these features demonstrate a 3-4 fold increased risk of having undiagnosed prediabetes compared to age-matched controls without skin tags. The correlation strengthens further when skin tags coexist with other dermatological signs of insulin resistance, such as acanthosis nigricans or androgenetic changes.

From a pathophysiological perspective, the development of skin tags may precede clinically detectable glucose abnormalities by several years. This temporal relationship exists because insulin resistance—the fundamental abnormality in prediabetes—affects dermatological tissues before producing significant alterations in glucose metabolism. The skin, with its high density of insulin receptors, effectively functions as an early responder to metabolic dysregulation.

For clinicians in London and beyond, this understanding creates an opportunity for proactive intervention. When patients present with multiple skin tags, particularly in the context of other risk factors such as obesity or family history, metabolic screening should be considered. Early identification of prediabetic states through dermatological assessment enables lifestyle interventions and monitoring that may prevent progression to overt diabetes, highlighting the importance of dermatological signs in metabolic syndrome.

Clinical Management of Skin Tags in Diabetic Patients

The approach to skin tag management in diabetic patients requires special considerations that balance cosmetic concerns, functional impairment, and metabolic implications. Treatment decisions should account for the increased risk of impaired wound healing, infection susceptibility, and potential for recurrence in this population. At our diabetic dermatology London practice, we employ a stratified approach based on patient-specific factors including glycaemic control, skin tag characteristics, and individual preferences.

For small, asymptomatic skin tags in well-controlled diabetic patients, observation remains a reasonable option. When intervention is indicated, cryotherapy with liquid nitrogen offers a quick, relatively painless option with minimal bleeding risk—an important consideration for diabetic patients who may experience delayed coagulation. This modality is particularly suitable for smaller lesions but may require multiple sessions for complete resolution.

Electrosurgery provides precise control and immediate results for larger skin tags. The simultaneous cutting and coagulation properties make it advantageous for diabetic patients, though careful attention to power settings helps minimise thermal damage to surrounding tissues. Snip excision with fine scissors followed by light electrodesiccation represents another effective approach, especially for pedunculated lesions. For diabetic patients, we routinely employ prophylactic antiseptic measures before and after these procedures to reduce infection risk.

Laser therapy, particularly using CO2 or Nd:YAG lasers, offers excellent precision with minimal bleeding and reduced infection risk—significant advantages for diabetic patients. However, this modality requires specialised equipment and expertise. Regardless of the technique selected, post-procedure care instructions for diabetic patients emphasise vigilant wound monitoring, meticulous hygiene, and prompt reporting of any delayed healing or signs of infection. Follow-up appointments are scheduled at shorter intervals compared to non-diabetic patients to ensure optimal healing and address any complications promptly.

Preventing Skin Tags Through Diabetes Control

The prevention of skin tags in diabetic patients fundamentally relies on achieving and maintaining optimal metabolic control. Evidence suggests that normalising insulin levels and improving insulin sensitivity can significantly reduce the incidence and recurrence of skin tags. This preventative approach addresses the root physiological mechanisms driving skin tag formation rather than merely treating the dermatological manifestations.

Glycaemic management forms the cornerstone of prevention. Studies demonstrate that patients who maintain HbA1c levels below 7% experience fewer new skin tags compared to those with poorer control. Regular monitoring of blood glucose levels, adherence to prescribed medications, and consistent medical follow-up create the foundation for effective prevention. For many patients, oral hypoglycaemic agents that specifically target insulin resistance, such as metformin, may offer dual benefits for both metabolic control and skin tag prevention.

Weight management represents another crucial preventative strategy. Research indicates that a 5-10% reduction in body weight can improve insulin sensitivity by 30-60%, significantly reducing the hormonal environment that promotes skin tag development. Structured weight loss programmes combining dietary modification, physical activity, and behavioural support have demonstrated efficacy in reducing both diabetes progression and dermatological manifestations of insulin resistance.

Nutritional interventions specifically targeting insulin resistance show promise in skin tag prevention. Diets emphasising low glycaemic index foods, adequate protein, healthy fats, and high fibre content help stabilise blood glucose levels and reduce insulin spikes. Limiting refined carbohydrates and processed foods while increasing consumption of vegetables, legumes, and whole grains creates a dietary pattern that supports both diabetic control and skin health.

Regular physical activity complements these approaches by enhancing glucose uptake in muscle tissue independent of insulin action. Both aerobic exercise and resistance training improve insulin sensitivity, with research suggesting that combined programmes yield the most significant benefits for metabolic health and, consequently, for preventing insulin-mediated skin changes including skin tags.

When to Seek Dermatological Care for Diabetic Skin Issues

Diabetic patients should establish lower thresholds for seeking dermatological consultation compared to the general population, as seemingly minor skin concerns can rapidly escalate due to impaired healing and immune function. Prompt dermatological evaluation is warranted when multiple new skin tags develop over a short period, particularly if accompanied by other dermatological manifestations of insulin resistance such as acanthosis nigricans. This pattern may signal worsening metabolic control requiring collaborative management between dermatology and endocrinology specialists.

Any skin tag that exhibits atypical features—including rapid growth, unusual pigmentation, bleeding, or pain—necessitates immediate dermatological assessment to rule out malignancy. While the vast majority of skin tags are benign, diabetic patients face increased risk of certain skin cancers, making vigilant monitoring essential. Skin tags that cause functional impairment through friction, recurrent trauma, or interference with clothing or jewellery also warrant professional evaluation, as these complications can create entry points for infection in diabetic skin.

Post-removal complications require particular attention in diabetic populations. Signs of impaired healing, including persistent redness, increased pain, purulent discharge, or wound expansion beyond 48 hours after a procedure, should trigger prompt dermatological review. Diabetic patients should also seek care for recurrent skin tags in previously treated areas, as this pattern may indicate suboptimal metabolic control requiring adjustment of diabetes management strategies.

Annual comprehensive skin examinations are recommended for all diabetic patients, regardless of whether they currently have skin tags or other dermatological manifestations. These preventative assessments enable early identification of diabetes-related skin changes and create opportunities for patient education regarding skin self-examination techniques. For patients with established diabetic dermatological conditions, more frequent monitoring schedules may be appropriate, typically at 3-6 month intervals depending on disease severity and glycaemic control.

At our diabetic dermatology specialist practice in London, we emphasise the importance of integrated care pathways that facilitate communication between dermatologists, endocrinologists, and primary care providers. This collaborative approach ensures that skin manifestations are considered within the broader context of metabolic health, enabling more effective management of both conditions simultaneously.

Frequently Asked Questions

Are skin tags a sign of diabetes?

Skin tags can be a potential indicator of diabetes, particularly Type 2 diabetes. Research shows diabetic patients are up to three times more likely to develop multiple skin tags compared to non-diabetic individuals. While not everyone with skin tags has diabetes, the presence of numerous skin tags, especially across multiple body areas, warrants consideration for metabolic screening. Skin tags often appear years before a formal diabetes diagnosis, making them valuable early warning signs.

How does insulin resistance cause skin tags?

Insulin resistance causes skin tags through several mechanisms: excess insulin activates insulin-like growth factor-1 (IGF-1) receptors in skin cells, stimulating cellular proliferation and inhibiting normal cell death; insulin enhances epidermal growth factors; and increases tissue sensitivity to growth hormones. Areas with skin folds like the neck and armpits have higher insulin receptor concentrations, explaining why skin tags commonly form in these regions. The number and size of skin tags often correlate with insulin resistance severity.

What other skin conditions are associated with diabetes?

Diabetes is associated with numerous skin conditions beyond skin tags, including: acanthosis nigricans (velvety, dark patches in body folds), diabetic dermopathy (“shin spots”), necrobiosis lipoidica diabeticorum (yellow-brown atrophic plaques), increased susceptibility to fungal and bacterial infections, diabetic bullae (spontaneous blisters), and xerosis (abnormally dry skin). These conditions often serve as visual indicators of glycemic control and may appear alongside skin tags in diabetic patients.

Can removing skin tags help with diabetes management?

Removing skin tags does not directly improve diabetes management, as they are a symptom rather than a cause of metabolic dysfunction. However, their removal can prevent complications like irritation or infection, which are particularly concerning for diabetic patients with compromised healing. The most effective approach combines appropriate removal of problematic skin tags with comprehensive diabetes management targeting the underlying insulin resistance that promotes their formation.

How can I prevent new skin tags if I have diabetes?

Preventing new skin tags with diabetes requires addressing the underlying metabolic issues: maintain optimal glycemic control (HbA1c below 7%); follow prescribed diabetes medications, particularly insulin-sensitizing agents like metformin; implement weight management strategies (even 5-10% weight loss can improve insulin sensitivity by 30-60%); adopt a low glycemic index diet rich in fiber, vegetables, and lean proteins; engage in regular physical activity combining both aerobic and resistance training; and reduce friction in areas prone to skin tags by wearing loose-fitting clothing.

When should diabetic patients see a dermatologist about skin tags?

Diabetic patients should consult a dermatologist when: multiple new skin tags develop rapidly; skin tags exhibit atypical features (unusual growth, color changes, bleeding, or pain); tags cause functional problems through friction or recurrent trauma; complications occur after removal (delayed healing, infection signs); or skin tags repeatedly recur in previously treated areas. Additionally, all diabetic patients benefit from annual comprehensive skin examinations regardless of current skin conditions.

Can skin tags appear before diabetes is diagnosed?

Yes, skin tags often appear before diabetes is formally diagnosed, sometimes by several years. They frequently develop during prediabetic states when insulin resistance is present but blood glucose levels haven’t yet reached diagnostic thresholds for diabetes. Individuals with multiple skin tags (typically more than five), larger skin tags (>5mm), or tags distributed across several body sites have a 3-4 fold increased risk of undiagnosed prediabetes. This makes skin tags valuable early indicators of metabolic dysfunction that warrant screening.

Back to all posts

Share this Post